Atossa Therapeutics is in the spotlight with its Phase 2 clinical trials, a crucial stage in assessing the efficacy and safety of their drug. Success here is vital for FDA approvals and advancing to later trials. However, the journey is fraught with challenges like regulatory hurdles and unpredictable trial outcomes, which can significantly sway the company's...
Average daily volume has been increasing since late May when it made a bullish pennant and a golden cross.
The ADX at 36 indicates a strong trend with D+ moving sharply higher.
Price broke out of the pennant (which corresponds to the descending trend line on the weekly) and looks very bullish as it appears to be flagging.
Most importantly we bullish...
NASDAQ:ATOS
It completed wave 3, and now wave 4 has started. It is expected to reach the 1.08 area soon, which aligns precisely with the Fibonacci retracements. After that, it should initiate wave 5, with the initial target being 1.60, followed by 2.10, which is a significant key level from 2021.
There is a possibility that market manipulators (MM) will create...
NASDAQ:ATOS
I anticipate a pullback to $0.85 as the Relative Strength Index (RSI) indicates an overbought condition. Based on Elliott Waves theory, a correction is expected, followed by the emergence of the fifth leg.
Following the pullback, if the price surpasses the psychological resistance level of $1, there are three potential price targets: $1.15, $1.30,...
*risky but the reward…*
Trawling through the Nasdaq at the 11th hour before a major correction reveals a number of interesting opportunities where the success of tech stocks have overshadowed the less successful of late.
This trade idea is 100% technical without focus on the fundamentals. Atossa is a small Therapeutics business with a limited number of...
we can easily do a triple bottom bounce off extreme support now, targeting 1.63-2.81-4.28 on a bounce with SL below extreme support zone.
can be a short play if support breaks as well
Atossa Therapeutics (ATOS) said Wednesday it has completed enrollment in part B of its phase 1/2a trial of drug candidate AT-H201 in Australia.
AT-H201 is being developed as an inhalation therapy for moderately to severely ill hospitalized COVID-19 patients and for "long-haul" patients with post-infection pulmonary disease, the clinical-stage drugmaker said. The...
We can see that the weekly chart is showing some exhaustion on the sell pressure. The daily has a bit of a heartbeat today breaking over the 20ema/ma.
Looking to see the weekly SARs flip underneath to support price, and a break over the T Line (EMA8) on the weekly to confirm a trend change.
If there is a solid break, targets (based on current price but will...
Head and Shoulders pattern from earlier this year almost fully manifested (see my previous post below)
Next support is around 2.00 and if that does not hold we are looking at 1.5 and 0.8
*This is not financial advice, so trade at your own risks*
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
$ATOS remains my teams best trade yet, but sadly for you guys this was...
- Looks like ATOS has formed a bullish deep crab pattern
- might move lower if we don't break 2.88 and define as support
- potential bottom if we break current low -> 1.79
- ATOS bounced of 200 SMA
- Low Volume indication of bottom -> Bullish Reversal
- Currently in ascending triangle -> Target 4.20 $
- MACD green
- Bollinger Bands contracting
- Road to +20$ has started!
It was a spectacular run for this stock, yet we seem to be at the end of the run. This is backed up by momentum divergences and dropping momentum overall. The latter is both on RSI and MACD. Indicator picture is more or less the same up to the daily chart. Our take on technical indicators is always secondary to the fractal picture of the markets. Anyway......
$ATOS - AND I’M OUT
I closed this position early today… The only reason is that my average is wrong here… I know exactly what I did (I was adding and I sold my position, then bought back in, then I didn’t know what my real average was anymore- sometimes I just go too fast and my OCD won’t let me not know my average LOL) 😬
So either way I’m out and I’ll be looking...
NASDAQ:ATOS
It's at 200EMA, and 3.31 is one of the key levels, it hit bounced up, it could be dead cat bounce (most likely), it's still in downtrend, without any reversal confirmation, I expect it hit 3.60 area, and then we will see what will happen, personally I expect price rejection to 2.80$ area and then 2.50$, GL
This is my idea and could be wrong 100%
